The Lanzavecchia Lab - Immune Regulation

Prof. em. Antonio Lanzavecchia

Prof. em. Antonio Lanzavecchia

ETH Zürich
Institut für Mikrobiologie
Vladimir-Prelog-Weg 1-5/10

8093 Zürich
Switzerland

email: 

The aim of the Lanzavecchia Lab was to unravel the basis of host resistance to infectious diseases to create a new generation of passive antibody therapies and vaccines. The human monoclonal antibodies that we isolated from memory B cells and plasma cells can be used not only as drugs for prophylaxis and treatment of infectious diseases, but also as tools to identify vaccine candidates. Besides these translational studies, we addressed fundamental issues with regard to the cellular basis of immunological memory, the role of somatic mutations in the generation of broadly neutralizing antibodies and the relationship between infection and autoimmunity.

external page Research projects

JavaScript has been disabled in your browser